Calcium antagonism by the antioestrogen tamoxifen

Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59: 606

Darbre PD, Curtis S, King RJ (1984) Effects of estradiol and tamoxifen on human breast cancer cells in serum free culture. Cancer Res 44: 2790

Edman KAP, Schild HO (1962) The need for calcium in the contractile reponses induced by acetylcholine and potassium in rat uterus. J Physiol (Lond) 161: 424

Endo M, Kitazawa T (1985) Separation of ?voltage? and ?receptor? phase for Ca2+. In: Godfraind et al. (eds) Calcium entry blockers and tissue protection. Raven Press, New York, pp 81?89

Fleckenstein A (1983) Calcium antagonism in heart and smooth muscle. Wiley, New York

Furr BJA, Jordan VC (1984) The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25: 127

Hesketh TR, Moore JP, Morris JDH, Taylor MV, Rogers J, Smith GA, Metcalfe JC (1985) A common sequence of calcium and pH signals in the mitogenic stimulation of eukaryotic cells. Nature 313: 481

Hickie RA, Wei JW, Blyth LM, Wong DY, Klaassen DJ (1983) Cations and ealmodulin in normal and neoplastic cell growth regulation. Can J Biochem Cell Biol 61: 934

Honn KV, Onoda JM, Pampalona K, Battaglia M, Neagos G, Taylor JD, Diglio CA, Sloane BF (1985) Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivo. Biochem Pharmacol 34: 235

Ichida S, Moriyama M, Terao M (1984) Characteristics of Ca influxed through voltage- and receptor-operated channels in uterine smooth muscle. J Pharmacol Exp Ther 228: 439

Ito H, Hidaka H (1983) Antitumor effect of a calmodulin antagonist on the growth of solid sacroma 180. Cancer Lett 19: 215

Jordan VC (1984) Biochemical pharmacology of antioestrogen action. Pharmacol Rev 36: 276

Lam HYP (1984) Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochem Biophys Res Commun 118: 27

Lippman ME (1983) Antiestrogen therapy of breast cancer. Semin Oncol 10/4 [Suppl 4]: 9

Lipton A, Vinijsanun A, Martin L (1984) Acute inhibition of rat myometrial responses to oxytocin by tamoxifen stereo-isomers and oestradiol. J Endocrinol 103: 383

Morris ID (1985) Inhibition of intestinal smooth muscle function by tamoxifen and clomiphene. Life Sci 37: 273

Reddel RR, Murphy LC, Sutherland RL (1983) Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. Cancer Res 43: 4618

Reddel RR, Murphy LC, Sutherland RL (1984) Factors affecting the sensitivity of T-47D human breast cells to tamoxifen. Cancer Res 44: 2398

Sezzi ML, Zupi G, De Luca G, Materazzi M, Bellelli L (1984) Effects of a calcium antagonist (flunarazine) on the in vitro growth of B16 mouse melanoma cells. Anticancer Res 4: 229

Taylor CM, Blanchard B, Zava DT (1984) Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxy tamoxifen. Cancer Res 44: 1409

Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y (1983) Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium channel blockers. Cancer Res 43: 2905

Van Breeman C, Hwang O, Siegel B (1977) In: Casteels R, Godfraind T, Ruegg JC (eds) Excitation contraction coupling in smooth muscle. Elsevier, Amsterdam, pp 243?252

Wei JW, Hickie RA, Klaassen DJ (1983) Inhibition of human breast cancer colony formation by anticalmodulin agents: Trifluoperazine, W7 and W13. Cancer Chemother Pharmacol 11: 86

Yoneda T, Kitamura M, Ogawa T, Shin-Ichiro A, Sakuda M (1985) Control of VX2 carcinoma cell growth in culture by calcium, calmodulin and prostaglandins. Cancer Res 45: 398